jaci.jp

Basic Website Information

jaci.jp is the official website of the Japanese Association for Cancer Immunology (JACI), which was founded in 1996. Its core mission is to advance the fundamental research of cancer immunotherapy in Japan, and provide academic exchange and information services for researchers in this field. The website is divided into four main sections: society governance information, academic conference services, industry news release, and research resource support.

Core Features and Content

The core functions of this website include:

• Regularly publishing society announcements and notifications from relevant industry institutions, updating official information such as council elections and grant programs
• Organizing the annual general meeting of the society and thematic seminars, and making abstract collections and records of past academic conferences publicly available for researchers to review and reference
• Compiling and releasing Japanese laws, regulations and clinical research guidelines related to cancer immunology and regenerative medicine, to provide reference for industry compliance
• Publishing open recruitment information for academic positions including faculty and research fellows
• Providing open technical support for researchers, including sharing HLA genotype information of cancer cell lines, and hosting various online research tools
• Publishing the society's e-newsletter and maintaining an archive of past issues

Advantages, Disadvantages and Target Users

For advantages: the website updates information in a timely manner, materials are clearly categorized, core academic resources are freely accessible to the public, and it provides researchers with useful basic data and tool support. The disadvantages are: the entire website only supports Japanese, which creates a high barrier for non-Japanese speakers; the interface is rather dated, and the user experience is only mediocre; it also does not disclose clear membership fee rules, and it has almost no practical value for the general public.
This website is suitable for use by researchers in the cancer immunology field, clinical investigators, and practitioners at relevant Japanese medical institutions.

Accessibility from China

Based on network access tests, this website can currently be accessed directly from China, no proxy tool is required.